(Q35184553)

7 August 2017

1 reference

title

Fulminant liver disease (English)

1 reference

7 August 2017

author name string

Frank Vinholt Schiødt

series ordinal

1

1 reference

7 August 2017

William M Lee

series ordinal

2

1 reference

7 August 2017

publication date

1 May 2003

1 reference

7 August 2017

published in

Clinics in liver disease

1 reference

7 August 2017

volume

7

1 reference

7 August 2017

issue

2

1 reference

7 August 2017

page(s)

331-49, vi

1 reference

Acute liver failure: redefining the syndromes

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

1 reference

7 January 2021

The American experience with transplantation for acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Fulminant hepatic failure: outcome after listing for highly urgent liver transplantation-12 years experience in the nordic countries

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Classification, etiology, and considerations of outcome in acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Etiology and outcome for 295 patients with acute liver failure in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Acute hepatic necrosis with stupor or coma. An analysis of thirty-one patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

A double-blinded, randomized trial of hydrocortisone in acute hepatic failure. The Acute Hepatic Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Fulminant hepatitis: Mayo Clinic experience with 34 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Etiology of fulminant viral hepatitis in Greece

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

The role of hepatitis C virus in fulminant viral hepatitis in an area with endemic hepatitis A and B.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Prevalence of hepatitis B or C virus infection in patients with fulminant viral hepatitis. An analysis using polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Hepatitis C virus-associated fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Fulminant hepatic failure in pregnant women: acute fatty liver or acute viral hepatitis?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Prevalence of herpesviridae and hepatitis B virus DNA in the liver of patients with non-A, non-B fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Acute non-A, non-B hepatitis in Kuwait

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Herpes simplex-induced fulminant hepatitis in adults: a call for empiric therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Fulminant hepatitis during herpes simplex virus infection in apparently immunocompetent adults: report of two cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Fulminant hepatitis due to Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Varicella-zoster virus infection associated with acute liver failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

A case of fatal infectious mononucleosis presenting with fulminant hepatic failure associated with an extensive CD8-positive lymphocyte infiltration in the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Hepatitis B virus genomes of patients with fulminant hepatitis do not share a specific mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Hepatitis B infection in patients with acute liver failure in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

INFLUENCE OF DELTA INFECTION ON SEVERITY OF HEPATITIS B

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Delta hepatitis. The disease and the virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Paracetamol (acetaminophen) poisoning

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Acetaminophen toxicity in an urban county hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Molecular mechanisms of the hepatotoxicity caused by acetaminophen

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Prediction of hepatic encephalopathy in paracetamol overdose: a prospective and validated study.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993)

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Cardiovascular, pulmonary and renal complications of fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Alcohol-acetaminophen syndrome. Even moderate social drinkers are at risk

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Influence of acute and chronic alcohol intake on the clinical course and outcome in acetaminophen overdose

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Acute versus chronic alcohol consumption in acetaminophen-induced hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Paracetamol, alcohol and the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Association of acetaminophen hepatotoxicity with fasting and ethanol use.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Clinical pharmacokinetics of paracetamol

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

The value of plasma acetaminophen half-life in antidote-treated acetaminophen overdosage

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Drug-induced hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Immunoallergic drug-induced hepatitis: lessons from halothane

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

The syndrome of methoxyflurane-associated hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Hepatic dysfunction after repeated isoflurane administration.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Isoniazid-associated hepatitis. Report of an outbreak

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Atorvastatin-induced acute hepatitis with absence of cross-toxicity with simvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

"Golf ball liver": agent orange hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Carbamazepine-induced acute cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Drug Points: Cholestatic hepatitis in association with celecoxib

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Interstitial nephritis, thrombocytopenia, hepatitis, and elevated serum amylase levels in a patient receiving clarithromycin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Liver damage induced by coumarin anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Case Report: Fatal Fulminant Hepatic Failure due to Cyproterone Acetate

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Hepatotoxicity induced by fosinopril

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Fatal acute hepatic necrosis due to fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Acute hepatitis due to fluoxetine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Indinavir-associated hepatitis in patients with advanced HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Acute fatal hepatitis related to levofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Mesalazine (5-aminosalicylic acid) induced chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Metformin-induced acute hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Nefazodone-induced liver failure: report of three cases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Norfloxacin-induced hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Norfloxacin-induced acute cholestatic hepatitis in a patient with alcoholic liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Paroxetine and hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Four cases of severe hepatotoxicity associated with pemoline: possible autoimmune pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Risperidone-induced cholestatic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Risperidone-induced hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Hepatitis associated with terbinafine therapy: three case reports and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Ticlopidine-induced cholestatic hepatitis: report of three cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

The rise and fall of tolcapone

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Trovafloxacin hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Valproate metabolism during valproate-associated hepatotoxicity in a surviving adult patient

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Venlafaxine-associated hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Coagulopathy of fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Cerebral edema and intracranial hypertension in acute liver failure: Distinct aspects of the same problem

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Cerebral metabolism of ammonia and amino acids in patients with fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Functional loss of cerebral blood flow autoregulation in patients with fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Hyperventilation restores cerebral blood flow autoregulation in patients with acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Restoration of cerebral blood flow autoregulation and reactivity to carbon dioxide in acute liver failure by moderate hypothermia

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Circulatory, respiratory, cerebral, and renal derangements in acute liver failure: pathophysiology and management

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Bacterial and fungal infection in acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Fungal infection: a common, unrecognised complication of acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985)

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Effects of penicillin and silymarin on liver enzymes and blood clotting factors in dogs given a boiled preparation of Amanita phalloides

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Acute liver failure due to hepatic involvement by hematologic malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

High volume plasma exchange in fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Fulminant hepatic failure and orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Use and outcome of liver transplantation in acetaminophen-induced acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

MINIMUM GRAFT VOLUME FOR SUCCESSFUL ADULT-TO-ADULT LIVING DONOR LIVER TRANSPLANTATION FOR FULMINANT HEPATIC FAILURE

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Early indicators of prognosis in fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Galactose elimination capacity as a prognostic index in patients with fulminant liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Functioning liver mass in uncomplicated and fulminant acute hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Arterial ketone body ratio as a possible indicator for liver transplantation in fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Relation of Alpha-Fetoprotein in Acute Hepatitis to Severity and Prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Prognostic value of hepatic volumetry in fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Emergency liver transplantation for acute liver failure. Evaluation of London and Clichy criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2803%2900026-6

7 January 2021

10.1016/S1089-3261(03)00026-6

Identifiers

DOI

1 reference

7 August 2017

1 reference